• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GPR
Click for more information
1.45% $3.01

Smartshares Global Property ETF Units

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
GPR
Ann: GPR NTA 19-09-2024 $2.96442 		20/09/24 0 33
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  33 
GPR
Ann: Name Change - Smartshares Exchange Traded Funds 		20/09/24 0 23
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  23 
GPR
Ann: GPR NTA 18-09-2024 $2.96458 		19/09/24 0 25
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  25 
GPR
Ann: GPR NTA 17-09-2024 $2.98791 		18/09/24 0 35
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  35 
GPR
Ann: GPR NTA 16-09-2024 $2.98639 		17/09/24 0 31
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  31 
GPR
Ann: GPR NTA 13-09-2024 $2.95741 		16/09/24 0 36
16/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
GPR
Ann: GPR NTA 12-09-2024 $2.94143 		13/09/24 0 36
13/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 
GPR
Ann: GPR NTA 11-09-2024 $2.93920 		12/09/24 0 36
12/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  36 

See All Discussions arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
(20min delay)
Last
$3.01 		Change
0.043(1.45%) 		Mkt cap ! n/a
Open High Low Value Volume
$3.01 $3.01 $3.01 $48 16
GPR (NZSX) Chart

Top Stories

Firetail executive changes set to propel development in Canada and Peru

Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.